Semantically enabling pharmacogenomic data for the realization of personalized medicine

Pharmacogenomics

Volumn 13, Issue 2, 2012, Pages 201-212

  Samwald, Matthias ^a,b   Coulet, Adrien ^c   Huerga, Iker ^d   Powers, Robert L ^e   Luciano, Joanne S ^f   Freimuth, Robert R ^g   Whipple, Frederick ^h   Pichler, Elgar ⁱ   Prudhommeaux, Eric ^j   Dumontier, Michel ^k   Marshall, M Scott ^l  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

^c INRIA   (France)

^d ELSEVIER MASSON   (France)

^e Predictive Medicine Inc   (United States)

^f RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^g MAYO CLINIC   (United States)

^h Genomics Education Initiative   (United States)

ⁱ NORTHEASTERN UNIVERSITY   (United States)

^j MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^k CARLETON UNIVERSITY   (Canada)

^l LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

clinical decision support systems; knowledge representation; ontologies; personalized medicine; pharmacogenomics; translational medicine

Indexed keywords

AUTOMATION; BIOINFORMATICS; CLINICAL DECISION MAKING; COMPUTER ANALYSIS; DATA ANALYSIS SOFTWARE; DECISION SUPPORT SYSTEM; GENETIC DATABASE; GENOTYPE; INFORMATION SERVICE; INTERNET; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PHENOTYPE; REVIEW; SEMANTICS;

DATABASES, GENETIC; HUMANS; INDIVIDUALIZED MEDICINE; INFORMATION SYSTEMS; INTERNET; PHARMACOGENETICS; SEMANTICS;

EID: 84855963774     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.11.179     Document Type: Review

References (42)

1. Hafner JW Jr, Belknap SM, Squillante MD, Bucheit KA. Adverse drug events in emergency department patients. Ann. Emerg. Med. 39(3), 258-267 (2002). (Pubitemid 34219639)
2. King CR, Deych E, Milligan P et al. Gamma-glutamyl carboxylase and its influence on warfarin dose. Thromb. Haemost. 104(4), 750-754 (2010).
3. Finkelman BS, Gage BF, Johnson JA, Brensinger CM, Kimmel SE. Genetic warfarin dosing. J. Am. Coll. Cardiol. 57(5), 612-618 (2011).
4. Estimation of the warfarin dose with clinical and pharmacogenetic data. N. Engl. J. Med. 360(8), 753-764 (2009).
5. Wishart DS, Knox C, Guo AC et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34(Suppl. 1), D668-D672 (2006).
6. Belleau F, Nolin M-A, Tourigny N, Rigault P, Morissette J. Bio2RDF: towards a mashup to build bioinformatics knowledge systems. J. Biomed. Inform. 41(5), 706-716 (2008).
7. Coulet A, Smaïl-Tabbone M, Napoli A, Devignes M-D. Ontology-based knowledge discovery in pharmacogenomics. Adv. Exp. Med. Biol. 696, 357-366 (2011).
8. Dumontier M, Villanueva-Rosales N. Towards pharmacogenomics knowledge discovery with the Semantic Web. Brief. Bioinform. 10(2), 153-163 (2009).
9. Heath T, Bizer C. Synthesis lectures on the Semantic Web: theory and technology. In: Linked Data: Evolving the Web into a Global Data Space. Hendler J, Van Harmelen F (Eds). Morgan and Claypool Publishers, San Rafael, CA, USA, 1, 1-136 (2011).
10. Kuhn M, Campillos M, Letunic I, Jensen LJ, Bork P. A side effect resource to capture phenotypic effects of drugs. Mol. Syst. Biol. 6, 343 (2010).
11. Samwald M, Jentzsch A, Bouton C et al. Linked open drug data for pharmaceutical research and development. J. Cheminform. 3, 19 (2011).
12. Volz J, Bizer C, Gaedke M, Kobilarov G. Silk-a link discovery framework for the web of data. Presented at: Proceedings of the 2nd Workshop Linked Data on the Web. 538, 1-6 (2009).
13. Ruttenberg A, Rees JA, Samwald M, Marshall MS. Life sciences on the Semantic Web: the neurocommons and beyond. Brief. Bioinform. 10(2), 193-204 (2009).
14. Luciano JS, Andersson B, Batchelor C et al. The Translational Medicine Ontology and Knowledge Base: driving personalized medicine by bridging the gap between bench and bedside. J. Biomed. Semantics 2(Suppl. 2), S1 (2011).
15. Demir E, Cary MP, Paley S et al. The BioPAX community standard for pathway data sharing. Nat. Biotechnol. 28(9), 935-942 (2010).
16. Jupp S, Klein J, Schanstra J, Stevens R. Developing a Kidney and Urinary Pathway Knowledge Base. J. Biomed. Semantics 2(Suppl. 2), S7 (2011).
17. Musen M, Shah N, Noy N. BioPortal: ontologies and data resources with the click of a mouse. AMIA Annu. Symp. Proc. 1223-1224 (2008).
18. Garten Y, Coulet A, Altman RB. Recent progress in automatically extracting information from the pharmacogenomic literature. Pharmacogenomics 11(10), 1467-1489 (2010).
19. Bodenreider O. Biomedical ontologies in action: role in knowledge management, data integration and decision support. Yearb. Med. Inform. 67-79 (2008).
20. Jonquet C, Lependu P, Falconer S et al. NCBO resource index: ontology-based search and mining of biomedical resources. Web Semantics (Online) 9(3), 316-324 (2011).
21. Coulet A, Garten Y, Dumontier M, Altman RB, Musen MA, Shah NH. Integration and publication of heterogeneous text-mined relationships on the Semantic Web. J. Biomed. Semantics 2, S10 (2011).
22. Cohen KB, Johnson HL, Verspoor K, Roeder C, Hunter LE. The structural and content aspects of abstracts versus bodies of full text journal articles are different. BMC Bioinformatics 11, 492 (2010).
23. Xu H, Jiang M, Oetjens M et al. Facilitating pharmacogenetic studies using electronic health records and natural-language processing: a case study of warfarin. J. Am. Med. Inform. Assoc. 18(4), 387-391 (2011).
24. Garten Y, Altman RB. Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text. BMC Bioinformatics 10(Suppl. 2), S6 (2009).
25. Tari L, Anwar S, Liang S, Hakenberg J, Baral C. Synthesis of pharmacokinetic pathways through knowledge acquisition and automated reasoning. Pac. Symp. Biocomput. 465-476 (2010).
26. Coulet A, Shah NH, Garten Y, Musen M, Altman RB. Using text to build semantic networks for pharmacogenomics. J. Biomed. Inform. 43(6), 1009-1019 (2010).
27. Laurila J, Naderi N, Witte R, Riazanov A, Kouznetsov A, Baker C. Algorithms and semantic infrastructure for mutation impact extraction and grounding. BMC Genomics. 11(Suppl. 4), S24 (2010).
28. Altman RB. Pharmacogenomics: 'noninferiority' is sufficient for initial implementation. Clin. Pharmacol. Ther. 89(3), 348-350 (2011).
29. Samwald M, Stenzhorn H, Dumontier M, Marshall MS, Luciano J, Adlassnig K-P. Towards an interoperable information infrastructure providing decision support for genomic medicine. Stud. Health Technol. Inform. 169, 165-169 (2011).
30. Heymans S, McKennirey M, Phillips J. Semantic validation of the use of SNOMED CT in HL7 clinical documents. J. Biomed. Semantics 2(1), 2 (2011).
31. Farkash A, Neuvirth H, Goldschmidt Y et al. A standard based approach for biomedical knowledge representation. Stud. Health Technol. Inform. 169, 689-693 (2011).
32. Gigerenzer G, Gaissmaier W, Kurz-Milcke E, Schwartz LM, Woloshin S. Helping doctors and patients make sense of health statistics. Psychol. Sci. Public Interest 8(2), 53-96 (2007).
33. Ginsburg GS, McCarthy JJ. Personalized medicine: revolutionizing drug discovery and patient care. Trends Biotechnol. 19(12), 491-496 (2001). (Pubitemid 33063607)
34. Klein TE, Chang JT, Cho MK et al. Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Pharmacogenomics J. 1(3), 167-170 (2001). (Pubitemid 33756654)
35. Webb AJ, Thorisson GA, Brookes AJ. An informatics project and online 'knowledge centre' supporting modern genotype-to-phenotype research. Hum. Mutat. 32(5), 543-550 (2011).
36. Mungall CJ, Batchelor C, Eilbeck K. Evolution of the sequence ontology terms and relationships. J. Biomed. Inform. 44(1), 87-93 (2011).
37. de Matos P, Alcántara R, Dekker A et al. Chemical entities of biological interest: an update. Nucleic Acids Res. 38(Database issue), D249-D254 (2010).
38. Nelson SJ, Zeng K, Kilbourne J, Powell T, Moore R. Normalized names for clinical drugs: RxNorm at 6 years. J. Am. Med. Inform. Assoc. 18(4), 441-448 (2011).
39. McDonald CJ, Huff SM, Suico JG et al. LOINC, a universal standard for identifying laboratory observations: a 5-year update. Clin. Chem. 49(4), 624-633 (2003). (Pubitemid 36382924)
40. Osborne JD, Flatow J, Holko M et al. Annotating the human genome with disease ontology. BMC Genomics 10(Suppl. 1), S6-S6 (2009).
41. Robinson PN, Köhler S, Bauer S, Seelow D, Horn D, Mundlos S. The human phenotype ontology: a tool for annotating and analyzing human hereditary disease. Am. J. Hum. Genet. 83(5), 610-615 (2008).
42. Rosse C, Mejino JLV Jr. A reference ontology for biomedical informatics: the foundational model of anatomy. J. Biomed. Inform. 36(6), 478-500 (2003). (Pubitemid 38169375)